Lazard US Mid Cap Equity Portfolio Institutional Shares (LZMIX)

19.76
Net Asset Value
-1.20%
1 Day
+4.72%
Year-to-Date
Overall Morningstar Rating
Mid-cap blend
Style or Category
No Load
Sales Expenses
1.45%
Expense Ratio
Below Average
Morningstar Risk Rating™
Investment Objective The investment seeks long-term capital appreciation. The Portfolio invests primarily in a focused portfolio of equity securities, principally common stocks, of mid cap U.S. companies that the Investment Manager believes have strong and/or improving financial productivity and are undervalued based on their earnings, cash flow or asset values. It invests at least 80% of its assets in equity securities of medium-size (mid cap) U.S. companies. The Portfolio may invest up to 20% of its assets in equity securities of larger or smaller U.S. or non-U.S. companies. It is non-diversified.

Performance

1 month-3.37% 3 years+17.69%
3 months-0.45% 5 years+14.41%
1 year+19.02% Since inception+8.70%
Data through --

Peer Comparisonvs. Mid-cap blend

 LZMIXCategory
Performance 5-yr return+14.41%+13.75%
Expense ratio1.45%1.19%
Risk 5 year sharpe ratio0.850.87
Net assets$39.0M$1.7B
Average market cap$8.1B$7.5B
Average P/E16.519.1
Portfolio turnover95%95%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyLazard
Fund manager & tenureAndrew Lacey / 14 Years
Minimal initial investment$100,000.00
Minimum IRA investment$100,000.00

Holdings

U.S. stock83.74%
International stock8.52%
Cash7.75%
Fixed income0.00%
Other0.00%
Top 5 Sectors
Portfolio weighting
Industrial materials 17.97%
Financial service 17.57%
Consumer goods 14.03%
Energy 12.88%
Consumer service 9.16%
Top 10 Holdings
Portfolio weighting
KSS Kohls Corp6.10%
VOYA Voya Financial Inc6.03%
AAP Advance Auto Parts Inc5.61%
MDCA MDC Partners Inc5.14%
DKS Dick's Sporting Goods Inc4.75%
ICE Intercontinental Exchange Inc4.72%
K Kellogg4.69%
CTXS Citrix Systems Inc4.34%
TAP Molson Coors Brewing Co4.05%
UTHR United Therapeutics Corp3.92%

To view my watchlist

Not a member yet?

Sign up now for a free account